Atlas FDA

ELECSYS ANTI-HCV IMMUNOASSAY ON MODULAR ANALYTICS E 170

FDA premarket approval P090009/S012 · decided 2014-09-19

Approval details

PMA number
P090009
Supplement
S012
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
ELECSYS ANTI-HCV IMMUNOASSAY ON MODULAR ANALYTICS E 170
Generic name
Assay, enzyme linked immunosorbent, hepatitis c virus
Applicant
Roche Diagnostics Corp.
Date received
2014-08-22
Decision date
2014-09-19
Days to decision
28 days
Decision code
OK30
Product code
MZO
Advisory committee
Microbiology
Expedited review
No
Location
Indianapolis, IN
Statement
CHANGE IN THE MANUFACTURING PROCESS FOR A BULK SOLUTION FORMULATION.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
SUPER SANI-CLOTH/ ACCU-CHEK INFORM II SYSTEM (K130138)Roche Diagnostics Corp.2013-03-15
ELECSYS CA 19-9 CALCHECK 5 (K101365)Roche Diagnostics Corp.2010-10-05
COBAS 8000 MODULAR SERIES ANALYZER (K100853)Roche Diagnostics Corp.2010-09-09
ACCU-CHEK ULTRFLEX INFUSION SET (K101196)Roche Diagnostics Corp.2010-08-27
AMPHETAMINES II ASSAY (K093664)Roche Diagnostics Corp.2010-07-28
ELECSYS INSULIN CALCHECK 5 (K101075)Roche Diagnostics Corp.2010-06-11
ELECSYS TESTOSTERONE II IMMUNOASSAY (K093421)Roche Diagnostics Corp.2010-04-23
ELECSYS TROPONIN T CALCHECK 5 (K092848)Roche Diagnostics Corp.2010-03-19